✦ LIBER ✦

Estrogen activity as a preventive and therapeutic target in thyroid cancer

✍ Scribed by Shilpi Rajoria; Robert Suriano; Andrea L. George; Arulkumaran Shanmugam; Casey Jussim; Edward J. Shin; Augustine L. Moscatello; Jan Geliebter; Angelo Carpi; Raj K. Tiwari

Book ID: 116314433
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 379 KB
Volume: 66
Category: Article
ISSN: 0753-3322
DOI: 10.1016/j.biopha.2011.11.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting the proteasome as a promising

Targeting the proteasome as a promising therapeutic strategy in thyroid cancer

✍ Annette Wunderlich; Tjadina Arndt; Melina Fischer; Silvia Roth; Annette Ramaswam 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB

Estrogen receptor β as a therapeutic tar

Estrogen receptor β as a therapeutic target for promoting neurogenesis and preventing neurodegeneration

✍ Liqin Zhao; Roberta Diaz Brinton 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 543 KB

The estrogen receptor as a target for br

The estrogen receptor as a target for breast cancer prevention

✍ Craig V. Jordan 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Estrogen receptor alpha negative breast

Estrogen receptor alpha negative breast cancer patients: Estrogen receptor beta as a therapeutic target

✍ George P. Skliris; Etienne Leygue; Peter H. Watson; Leigh C. Murphy 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 913 KB

Estrogen receptor as a target for the pr

Estrogen receptor as a target for the prevention of breast cancer

✍ V.Craig Jordan 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 637 KB

Targeting mitochondria as a therapeutic

Targeting mitochondria as a therapeutic target in cancer

✍ Charles E. Wenner 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB 👁 1 views

## Abstract Knowledge of re‐programming in cancer cells with metabolic differences from their normal counterparts has resulted in new examination of therapeutic approaches. Several studies of the role of tumor mitochondria in cancer have led to the development of non‐genotoxic therapies which targe